查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1956801

动物驱虫药市场分析及预测（至2035年）：类型、产品、应用、最终用户、剂型、技术、组件、阶段、模式与安装类型

Animal Parasiticides Market Analysis and Forecast to 2035: Type, Product, Application, End User, Form, Technology, Component, Stage, Mode, Installation Type
出版日期: | 出版商: Global Insight Services | 英文 392 Pages | 商品交期: 3-5个工作天内

价格
简介目录

动物驱虫市场预计将从2024年的101亿美元成长到2034年的165亿美元，复合年增长率约为5%。动物驱虫市场涵盖用于预防和消除动物寄生虫感染的产品，包括体内寄生虫杀灭剂、体外寄生虫杀灭剂和Endectocides用途杀虫剂。这些产品对于维持牲畜和伴侣动物的健康和生产力至关重要。推动市场成长的因素包括动物健康意识的提高、畜牧业生产的成长以及兽医的进步。创新重点在于提高频谱疗效、简化给药流程和增强安全性，以满足日益增长的有效寄生虫控制解决方案的需求。

受动物健康意识增强和宠物主人数量不断增长的推动，动物驱虫市场正经历强劲增长。其中，体内寄生虫防治剂是成长最快的细分市场，对控制牲畜和伴侣动物体内寄生虫至关重要。口服製剂因其给药方便、疗效显着，在该细分市场中占据主导地位。其次是体外寄生虫防治剂，用于控制跳蚤和蜱虫等体外寄生虫。滴剂製剂在该细分市场中尤其受欢迎，因为它给药方便，且能提供持久的保护。牲畜市场是推动市场成长的主要动力，反映了肉类和乳製品需求的成长。由于宠物人性化趋势的日益增强，伴侣动物市场也蕴藏着巨大的成长潜力。驱虫製剂的创新，例如复方製剂和新型活性成分，正在提高驱虫药的疗效和安全性。越来越多的新产品获得监管部门核准，进一步推动了市场扩张，并为业内相关人员提供了盈利的机会。

市场区隔
类型 体内杀寄生虫剂、体外杀寄生虫剂、Endectocides
产品 口服药片、注射、外用/滴剂、喷雾、项圈、洗髮精和浸浴剂
目的 兽医诊所、畜牧场、家庭护理、研究机构
最终用户 伴侣动物、牲畜和水产养殖
形式 液体、固体、半固体
科技 化学合成，生物来源成分
成分 活性成分、添加剂
阶段 开发与商业化
模式 预防和治疗
安装类型 独立式、整合式

动物驱虫药市场的特点是市场份额波动较大，这主要受竞争激烈的价格策略和不断涌现的创新产品的影响。各公司正利用先进的配方技术和给药方式来抢占关键市场，并提高药效和用户便利性。策略联盟和收购也十分频繁，使公司能够扩展产品系列和地理覆盖范围。价格竞争依然激烈，主要受原物料成本和监管合规性的影响，而成本效益是打入新兴市场的关键。主要产业参与者不断相互比较，以保持竞争优势，这构成了竞争格局的特征。法规结构，尤其是在北美和欧洲，在塑造市场动态、影响市场核准和打入市场策略发挥着至关重要的作用。此外，严格的环境法规和消费者需求正在推动市场转向环保和永续的驱虫产品。这种法规环境与技术进步相结合，既给市场参与者带来了挑战，也带来了机会。

主要趋势和驱动因素：

由于人们对动物健康和福利的意识不断增强，动物驱虫市场正在成长。这一趋势主要受对高品质动物性食品需求不断增长的推动。消费者健康意识的提高，使得他们越来越倾向于选择无病虫害的肉类和乳製品。这导致驱虫产品的使用量激增，以确保牲畜的健康和生产力。兽医领域的科技创新也正在推动市场发展。药物配方和给药方式的创新提高了驱虫产品的疗效和安全性，促使兽医和养殖户更多地使用驱虫产品。此外，伴侣动物数量的增加和宠物医疗保健支出的成长也促进了市场扩张。世界各国政府的监管支持也是一个关键驱动因素。各国政府正在实施严格的法规来遏制寄生虫感染，从而推动了对有效驱虫产品的需求。此外，新兴国家畜牧业的扩张也为市场参与者带来了盈利的机会。专注于研发以推出新颖环保产品的公司，更有可能充分利用这些机会。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 体内杀寄生虫剂
    • 体外寄生虫杀灭剂
    • 体内和体外杀寄生虫剂
  • 市场规模及预测：依产品划分
    • 口服锭剂
    • 注射
    • 倾倒式，精准到位
    • 喷
    • 衣领
    • 洗髮精
    • 沾酱
  • 市场规模及预测：依应用领域划分
    • 兽医诊所
    • 畜牧场
    • 居家照护
    • 研究所
  • 市场规模及预测：依最终用户划分
    • 伴侣动物
    • 家畜
    • 水产养殖
  • 市场规模及预测：依类型
    • 液体
    • 固体的
    • 半固态
  • 市场规模及预测：依技术划分
    • 化学合成
    • 生物来源製品
  • 市场规模及预测：依组件划分
    • 活性成分
    • 添加剂
  • 市场规模及预测：依阶段划分
    • 发展
    • 商业化
  • 市场规模及预测：按模式
    • 预防
    • 治疗
  • 市场规模及预测：依安装类型划分
    • 独奏
    • 一体化

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章：公司简介

  • Vetoquinol
  • Virbac
  • Phibro Animal Health
  • Dechra Pharmaceuticals
  • Neogen Corporation
  • Bimeda
  • Ceva Sante Animale
  • Norbrook Laboratories
  • Huvepharma
  • Elanco Animal Health
  • Eco Animal Health
  • Sequent Scientific
  • Karyopharm Therapeutics
  • Zydus Animal Health
  • Biogenesis Bago
  • Intas Pharmaceuticals
  • KRKA
  • Bayer Animal Health
  • Orion Corporation
  • Ashish Life Science

第九章：关于我们

简介目录
Product Code: GIS20674

Animal Parasiticides Market is anticipated to expand from $10.1 billion in 2024 to $16.5 billion by 2034, growing at a CAGR of approximately 5%. The Animal Parasiticides Market encompasses products designed to prevent and eliminate parasitic infections in animals, including endoparasiticides, ectoparasiticides, and endectocides. These products are essential for maintaining animal health and productivity across livestock and companion animals. The market is driven by rising awareness of animal health, increasing livestock production, and advancements in veterinary pharmaceuticals. Innovations focus on broad-spectrum efficacy, ease of administration, and safety, addressing the growing demand for effective parasite management solutions.

The Animal Parasiticides Market is experiencing robust growth, driven by increasing awareness of animal health and rising pet ownership. The top-performing segment is the endoparasiticides, essential for controlling internal parasites in livestock and companion animals. Within this segment, oral formulations are leading due to their ease of administration and effectiveness. The second highest-performing segment is the ectoparasiticides, crucial for managing external parasites such as fleas and ticks. Spot-on formulations are particularly popular in this sub-segment, offering convenient application and long-lasting protection. The livestock animal category dominates, reflecting the growing demand for meat and dairy products. Companion animals also show significant growth potential, driven by the rising trend of pet humanization. Innovations in parasiticide formulations, such as combination products and novel active ingredients, are enhancing efficacy and safety. Increasing regulatory approvals for new products further support market expansion, providing lucrative opportunities for industry players.

Market Segmentation
TypeEndoparasiticides, Ectoparasiticides, Endectocides
ProductOral Tablets, Injectables, Pour-on and Spot-on, Sprays, Collars, Shampoos, Dips
ApplicationVeterinary Clinics, Animal Farms, Home Care, Research Institutes
End UserCompanion Animals, Livestock, Aquaculture
FormLiquid, Solid, Semi-Solid
TechnologyChemical Synthesis, Biological Derivatives
ComponentActive Ingredients, Excipients
StageDevelopment, Commercialization
ModePreventive, Curative
Installation TypeStandalone, Integrated

The Animal Parasiticides Market is characterized by a dynamic distribution of market share, driven by a blend of competitive pricing strategies and a steady stream of innovative product launches. Companies are leveraging advanced formulations and delivery methods to enhance efficacy and user convenience, thereby capturing significant market segments. Strategic alliances and acquisitions are prevalent, as firms seek to expand their portfolios and geographic reach. Pricing remains competitive, influenced by raw material costs and regulatory compliance, with a focus on cost-effectiveness to penetrate emerging markets. The competitive landscape is marked by the presence of key industry players who are consistently benchmarking against each other to maintain a competitive edge. Regulatory frameworks, particularly in North America and Europe, play a pivotal role in shaping market dynamics, influencing product approvals and market entry strategies. The market is also witnessing a shift towards eco-friendly and sustainable parasiticides, driven by stringent environmental regulations and consumer demand. This regulatory environment, coupled with technological advancements, presents both challenges and opportunities for market players.

Geographical Overview:

The animal parasiticides market is witnessing robust growth across various regions, each with unique dynamics. North America remains a dominant force, driven by advanced veterinary healthcare infrastructure and heightened awareness of animal health. The region's strong focus on livestock health and companion animal care fuels demand for parasiticides. Europe follows closely, supported by stringent regulations and high adoption rates of veterinary solutions. In Asia Pacific, rapid urbanization and increasing pet ownership are propelling market expansion. Countries like China and India are emerging as lucrative markets due to rising disposable incomes and growing awareness of animal welfare. Latin America and the Middle East & Africa are also gaining traction. In Latin America, the agricultural sector's expansion and livestock industry are key growth drivers. Meanwhile, the Middle East & Africa are recognizing the importance of animal health in improving food security and economic stability, thereby creating new growth pockets in the market.

Global tariffs and geopolitical tensions are significantly influencing the Animal Parasiticides Market, particularly in Japan, South Korea, China, and Taiwan. Japan and South Korea are strategically diversifying their import sources to mitigate tariff impacts, while China is bolstering domestic production capabilities to reduce reliance on imports. Taiwan, with its advanced biotech sector, is focusing on innovation to maintain competitiveness amidst trade uncertainties. The parent market is experiencing steady growth globally, driven by increased livestock farming and pet ownership. By 2035, the market is expected to evolve with a greater emphasis on sustainable and locally produced parasiticides. Additionally, Middle East conflicts are affecting global supply chains and energy prices, indirectly impacting production costs and logistics in the animal health sector.

Key Trends and Drivers:

The Animal Parasiticides Market is experiencing growth due to heightened awareness of animal health and welfare. This trend is driven by the increasing demand for high-quality animal-derived food products. As consumers become more health-conscious, there is a growing preference for meat and dairy products free from diseases and parasites. This has led to a surge in the use of parasiticides to ensure the health and productivity of livestock. Technological advancements in veterinary medicine are also driving the market. Innovations in drug formulations and delivery methods have enhanced the efficacy and safety of parasiticides. This has encouraged their widespread adoption among veterinarians and farmers. Furthermore, the rise of companion animals, coupled with increased spending on pet healthcare, is contributing to market expansion. Regulatory support from governments worldwide is another significant driver. Authorities are implementing stringent regulations to control parasitic infections, thereby boosting the demand for effective parasiticides. Additionally, the expanding livestock industry in emerging economies presents lucrative opportunities for market players. Companies focusing on research and development to introduce novel and eco-friendly products are well-positioned to capitalize on these opportunities.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Application
  • 2.4 Key Market Highlights by End User
  • 2.5 Key Market Highlights by Form
  • 2.6 Key Market Highlights by Technology
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Stage
  • 2.9 Key Market Highlights by Mode
  • 2.10 Key Market Highlights by Installation Type

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Endoparasiticides
    • 4.1.2 Ectoparasiticides
    • 4.1.3 Endectocides
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Oral Tablets
    • 4.2.2 Injectables
    • 4.2.3 Pour-on and Spot-on
    • 4.2.4 Sprays
    • 4.2.5 Collars
    • 4.2.6 Shampoos
    • 4.2.7 Dips
  • 4.3 Market Size & Forecast by Application (2020-2035)
    • 4.3.1 Veterinary Clinics
    • 4.3.2 Animal Farms
    • 4.3.3 Home Care
    • 4.3.4 Research Institutes
  • 4.4 Market Size & Forecast by End User (2020-2035)
    • 4.4.1 Companion Animals
    • 4.4.2 Livestock
    • 4.4.3 Aquaculture
  • 4.5 Market Size & Forecast by Form (2020-2035)
    • 4.5.1 Liquid
    • 4.5.2 Solid
    • 4.5.3 Semi-Solid
  • 4.6 Market Size & Forecast by Technology (2020-2035)
    • 4.6.1 Chemical Synthesis
    • 4.6.2 Biological Derivatives
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Active Ingredients
    • 4.7.2 Excipients
  • 4.8 Market Size & Forecast by Stage (2020-2035)
    • 4.8.1 Development
    • 4.8.2 Commercialization
  • 4.9 Market Size & Forecast by Mode (2020-2035)
    • 4.9.1 Preventive
    • 4.9.2 Curative
  • 4.10 Market Size & Forecast by Installation Type (2020-2035)
    • 4.10.1 Standalone
    • 4.10.2 Integrated

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Application
      • 5.2.1.4 End User
      • 5.2.1.5 Form
      • 5.2.1.6 Technology
      • 5.2.1.7 Component
      • 5.2.1.8 Stage
      • 5.2.1.9 Mode
      • 5.2.1.10 Installation Type
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Application
      • 5.2.2.4 End User
      • 5.2.2.5 Form
      • 5.2.2.6 Technology
      • 5.2.2.7 Component
      • 5.2.2.8 Stage
      • 5.2.2.9 Mode
      • 5.2.2.10 Installation Type
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Application
      • 5.2.3.4 End User
      • 5.2.3.5 Form
      • 5.2.3.6 Technology
      • 5.2.3.7 Component
      • 5.2.3.8 Stage
      • 5.2.3.9 Mode
      • 5.2.3.10 Installation Type
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Application
      • 5.3.1.4 End User
      • 5.3.1.5 Form
      • 5.3.1.6 Technology
      • 5.3.1.7 Component
      • 5.3.1.8 Stage
      • 5.3.1.9 Mode
      • 5.3.1.10 Installation Type
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Application
      • 5.3.2.4 End User
      • 5.3.2.5 Form
      • 5.3.2.6 Technology
      • 5.3.2.7 Component
      • 5.3.2.8 Stage
      • 5.3.2.9 Mode
      • 5.3.2.10 Installation Type
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Application
      • 5.3.3.4 End User
      • 5.3.3.5 Form
      • 5.3.3.6 Technology
      • 5.3.3.7 Component
      • 5.3.3.8 Stage
      • 5.3.3.9 Mode
      • 5.3.3.10 Installation Type
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Application
      • 5.4.1.4 End User
      • 5.4.1.5 Form
      • 5.4.1.6 Technology
      • 5.4.1.7 Component
      • 5.4.1.8 Stage
      • 5.4.1.9 Mode
      • 5.4.1.10 Installation Type
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Application
      • 5.4.2.4 End User
      • 5.4.2.5 Form
      • 5.4.2.6 Technology
      • 5.4.2.7 Component
      • 5.4.2.8 Stage
      • 5.4.2.9 Mode
      • 5.4.2.10 Installation Type
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Application
      • 5.4.3.4 End User
      • 5.4.3.5 Form
      • 5.4.3.6 Technology
      • 5.4.3.7 Component
      • 5.4.3.8 Stage
      • 5.4.3.9 Mode
      • 5.4.3.10 Installation Type
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Application
      • 5.4.4.4 End User
      • 5.4.4.5 Form
      • 5.4.4.6 Technology
      • 5.4.4.7 Component
      • 5.4.4.8 Stage
      • 5.4.4.9 Mode
      • 5.4.4.10 Installation Type
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Application
      • 5.4.5.4 End User
      • 5.4.5.5 Form
      • 5.4.5.6 Technology
      • 5.4.5.7 Component
      • 5.4.5.8 Stage
      • 5.4.5.9 Mode
      • 5.4.5.10 Installation Type
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Application
      • 5.4.6.4 End User
      • 5.4.6.5 Form
      • 5.4.6.6 Technology
      • 5.4.6.7 Component
      • 5.4.6.8 Stage
      • 5.4.6.9 Mode
      • 5.4.6.10 Installation Type
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Application
      • 5.4.7.4 End User
      • 5.4.7.5 Form
      • 5.4.7.6 Technology
      • 5.4.7.7 Component
      • 5.4.7.8 Stage
      • 5.4.7.9 Mode
      • 5.4.7.10 Installation Type
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Application
      • 5.5.1.4 End User
      • 5.5.1.5 Form
      • 5.5.1.6 Technology
      • 5.5.1.7 Component
      • 5.5.1.8 Stage
      • 5.5.1.9 Mode
      • 5.5.1.10 Installation Type
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Application
      • 5.5.2.4 End User
      • 5.5.2.5 Form
      • 5.5.2.6 Technology
      • 5.5.2.7 Component
      • 5.5.2.8 Stage
      • 5.5.2.9 Mode
      • 5.5.2.10 Installation Type
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Application
      • 5.5.3.4 End User
      • 5.5.3.5 Form
      • 5.5.3.6 Technology
      • 5.5.3.7 Component
      • 5.5.3.8 Stage
      • 5.5.3.9 Mode
      • 5.5.3.10 Installation Type
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Application
      • 5.5.4.4 End User
      • 5.5.4.5 Form
      • 5.5.4.6 Technology
      • 5.5.4.7 Component
      • 5.5.4.8 Stage
      • 5.5.4.9 Mode
      • 5.5.4.10 Installation Type
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Application
      • 5.5.5.4 End User
      • 5.5.5.5 Form
      • 5.5.5.6 Technology
      • 5.5.5.7 Component
      • 5.5.5.8 Stage
      • 5.5.5.9 Mode
      • 5.5.5.10 Installation Type
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Application
      • 5.5.6.4 End User
      • 5.5.6.5 Form
      • 5.5.6.6 Technology
      • 5.5.6.7 Component
      • 5.5.6.8 Stage
      • 5.5.6.9 Mode
      • 5.5.6.10 Installation Type
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Application
      • 5.6.1.4 End User
      • 5.6.1.5 Form
      • 5.6.1.6 Technology
      • 5.6.1.7 Component
      • 5.6.1.8 Stage
      • 5.6.1.9 Mode
      • 5.6.1.10 Installation Type
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Application
      • 5.6.2.4 End User
      • 5.6.2.5 Form
      • 5.6.2.6 Technology
      • 5.6.2.7 Component
      • 5.6.2.8 Stage
      • 5.6.2.9 Mode
      • 5.6.2.10 Installation Type
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Application
      • 5.6.3.4 End User
      • 5.6.3.5 Form
      • 5.6.3.6 Technology
      • 5.6.3.7 Component
      • 5.6.3.8 Stage
      • 5.6.3.9 Mode
      • 5.6.3.10 Installation Type
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Application
      • 5.6.4.4 End User
      • 5.6.4.5 Form
      • 5.6.4.6 Technology
      • 5.6.4.7 Component
      • 5.6.4.8 Stage
      • 5.6.4.9 Mode
      • 5.6.4.10 Installation Type
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Application
      • 5.6.5.4 End User
      • 5.6.5.5 Form
      • 5.6.5.6 Technology
      • 5.6.5.7 Component
      • 5.6.5.8 Stage
      • 5.6.5.9 Mode
      • 5.6.5.10 Installation Type

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Vetoquinol
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Virbac
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Phibro Animal Health
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Dechra Pharmaceuticals
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Neogen Corporation
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Bimeda
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Ceva Sante Animale
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Norbrook Laboratories
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Huvepharma
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Elanco Animal Health
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Eco Animal Health
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Sequent Scientific
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Karyopharm Therapeutics
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Zydus Animal Health
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Biogenesis Bago
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Intas Pharmaceuticals
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 KRKA
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Bayer Animal Health
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Orion Corporation
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Ashish Life Science
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us